Targeted Oncology

Same-Day Multidisciplinary Oncology Clinics May Improve Care Efficiency, Study Suggests

According to a recent systematic review published in JCO Oncology Practice, implementation of same-day multidisciplinary ...
The Lancet

Age- and sex-specific attributable impact of modifiable risk factors on atherosclerotic cardiovascular disease in Korea: a nationwide population-based cohort study

These findings reveal distinct age- and sex-specific patterns in the burden of modifiable risk factors in contemporary Koreans. Tailored prevention strategies that reflect national epidemiological ...
CURE

Bezuclastinib Submitted to FDA for Patients With Previously Treated GIST

FDA NDA for bezuclastinib targets post-imatinib GIST, leveraging Real-Time Oncology Review and prior breakthrough therapy ...

Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Late-line Patients with Microsatellite Stable Colorectal Cancer Demonstrate ...

Dose-Dependent Efficacy Results : As of the latest data cut, muzastotugachieved a 31% (8/26) confirmed overall response rate (ORR) in the combined 20 mg/kg dose cohorts, showing a clear improvement ...